Ticker ACIU – AC Immune – sales, description, marketcap – Tickerday.com

ACIU

AC Immune

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 345.64M; Volume: 500.78K; AvgVol 3m: 1.15M; Beta: 0.79;

Cost estimate:

P/E: –; EPS: -0.37; EPS growth quarter/prev quarter: 8.30%;

EPS growth this year: 177.60%; EPS growth past 5 years: 26.30%;

EPS ttm: -0.38;

P/S: 6.76; P/B: 1.30; P/Cashflow: 1.24; P/FCF: ;

Sales: 1.06M; Sales growth quarter/prev quarter: -13.30%; Sales growth past 5 years: 29.70%;

Profitability:

Gross Margin: ; Profit Margin: -51.20%; Operating Margin: -49.40%;

ROA – return on assets: -8.40%; ROE – return on equity: -9.10%; LT Debt/Equity: 0.01; Total Debt/Equity: 0.01;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 47.90%; Insider Transactions:0.00%;

Institutional Ownership: 28.90%; Institutional Transactions: 2.03%;

Data update: 07.10.2020.